Transition/Home Visit Guidelines during COVID 19

Updated 08/11/21 (revision of 03/24/21, 02/24/21, 10/20/20)

Individuals that are supported in State Operated Centers (SODC's) will be eligible for transition/home visitations when the following safety and health criteria have been met:

The Center and Residential Unit:

  1. The Center is currently in a region with Illinois Phase 4 or 5 reopening status (not in tiered mitigations), not in facility wide outbreak status and the residential area is not in quarantine or isolation.
  2. The Center does a pre-visit at the CILA/Provider to ensure that social distancing, use of face masks and environmental measures are in place and in use at the provider.
  3. The residential area at the Center and the CILA/Provider or home visit site has had no positive COVID 19 cases in residents or staff within the past 14 days.
  4. There is no epidemiologic linked COVID-19 positive staff, or otherwise PUI (person under investigation), associated with the residential area at the Center and/or the CILA/Provider or home visit site within the past 14 days.
  5. In the event of a new exposure to COVID-19 at the Center, CILA/Provider or home visit site or members, for the health and wellbeing of the people we support, transition visitations will be suspended for the impacted residential area at the Center or for the impacted provider/home. Visitation may be considered following 14 days from the last positive case of COVID-19 at either the impacted area of the Center, the provider or home. This will be determined in conjunction with the SODC COVID 19 IC team.

The Resident:

  1. 1. The resident's team has met and documented that this visit is a necessary step toward independence of the resident or for his/her psycho-social well-being.
  2. Only residents who are not in isolation or quarantine for COVID-19 will attend transition/home visits.
  3. Residents who are without signs or symptoms of COVID-19 like illness including: Fever (100.0 F or greater); chills; cough; shortness of breath or difficulty breathing; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea; persistent chest pain or pressure; new onset confusion; inability to wake or stay awake; bluish lips or face.
  4. Any resident leaving the center for more than 24 hours regardless of vaccination status will need to quarantine away from others for 14 days.

COVID -19 Information for CILA/Provider or guardian/family:

  1. Prior to the visit a meeting will be held with the provider/guardian/family member and members of the Center core team.
  2. The Center will inform the provider/guardian/family of the signs and symptoms of COVID-19, the guidelines that will be followed for the visit and contact information at the Center should issues arise during the visit.

Follow up during visit:

  1. The Center must have daily contact with the provider during the visit which includes review of any medical conditions or signs and symptoms in the resident visiting, and if there are any residents at the provider that have developed signs or symptoms of COVID.
  2. For a home visit the Center will discuss COVID 19 precautions with the guardian/family member before the visit. Upon return from the visit a risk assessment will be conducted with the input of the guardian/family member if the resident if the visit is < 24 hours.

COVID-19 Testing prior to transition/home visit.

  1. SARS-CoV-2 PCR or antigen testing should be performed prior to a transition/home visit.
  2. When PCR testing is used, sample collection should never exceed 72 hrs prior to a visit.
  3. If PCR testing cannot be reliably processed within 48 hours prior to the visit, proceed with rapid antigen testing.
  4. If utilizing antigen testing, it should be completed within 24 hours prior to the visit.

COVID-19 Testing upon return from transition/home visit stay overnight or longer.

  1. SARS-CoV-2 PCR or antigen testing should be performed immediately upon return from the visit, and 7 days later. The resident should be quarantined in a private setting for 14 days regardless of vaccination status or have signs or symptoms of COVID 19. The quarantine period cannot be shortened even with negative test results. Per clinical judgement the treating physician may decide to obtain additional testing for COVID-19 and/or another potential pathogen(s).
  2. If either test is positive, or if COVID-19 like signs or symptoms develop, the resident should be placed in isolation, per facility protocol. The guidelines for monitoring a resident in isolation or quarantine must be followed.

Risk Assessment for Transition or Home Visits/Trips that are less than 24 hours and do not involve overnight.

  1. 1. The provider or family/guardian must agree to abide by social distancing, wearing of masks (less than 15 minutes of contact time without mask on), and environmental disinfection during the short term (non-overnight) visit.
  2. If the transition or home visit is less than 24 hours and does not involve an overnight stay, a risk assessment will be performed using the COVID 19 LTC Facility Risk Assessment Questionnaire if the resident is not fully vaccinated to determine if quarantine upon return is needed.

Transporting to and from CILA/Provider/Home (Refer to Transporting of Patients During COVID-19).

  1. The policy and procedure for transporting individuals must be strictly adhered to when transporting residents to and from a transition visit or from a home visit if facility transport is utilized.
  2. In the event a resident develops COVID-19 like symptoms while at a visit, and symptoms are severe, including but not limited to difficulty breathing/shortness of breath; chest pain/pressure; bluish lips/face; lethargy/inability to wake or stay awake, than the resident should be transported by emergency services to the nearest hospital emergency department.
  3. If the resident has mild to moderate symptoms and immediate hospitalization is not necessary, the resident may be transported to the Center, by center vehicle, but only after consultation with and approval by a center physician following the policy and procedure for transporting residents with COVID-19 like symptoms.